Bio B2B 〉 Selective Search Results
Your Selection Setting ：Specialty Pharma；
Selective Search Results :
Biotech Companies 17 record(s)；
Intech Biopharm Ltd.
We are a pharmaceutical company that develops, produces and markets specialized drugs focusing on the respiratory treatment categories. By owning strong RD team and the superior HFA MDI platforms with facilities at the high level as EMA and US FDA standard, we are not only challenge high barrier generic drugs but also develop 505b2 and new combination drug for obstructive airway diseases.
Lumosa Therapeutics Co., Ltd.
Lumosa Therapeutics is dedicated to the development of innovative new drugs for the treatment of unmet medical needs in the fields of neurological and inflammatory diseases. The company is actively engaged in scientific licensing and new drug development under a “reSEARCH and DEVELOPMENT” model. We “search” for candidates with strong scientific rationale and high feasibility
PhytoHealth Corporation, a member of Maywufa Biopharma Group of companies, was incorporated in 1998 as a new drug development company with focus on research & development, clinical trial, manufacturing, marketing & sales of novel botanical drugs and chemically synthesized drugs.PhytoHealth successfully held its IPO in 2002, being the first new drug development company to be listed
INNOPHARMAX is a specialty pharmaceutical company focused in the development and commercialization of products for the treatment of oncology and specialty. We internally develop and/or acquire potential drug candidates for further clinical development as well as commercialization. We intend to use internally developed drug delivery technology platforms for improving the safety and efficacy
SINEW PHARMA INC.
Sinew Pharma was established in 2014 to aim at the current world urgent important unmet medical needs. The technology platform was based on the modulation of hepatic metabolic enzymes and genes. Among 6 core products, 2 were developed for the treatment of non-alcoholic steatohepatitis (NASH), 4 for the most widely used analgesics acetaminophen related hepatotoxicity.SNP-610 was approved by USFDA
Taiwan Advance Bio-Pharmaceutical Inc.
Invested by Taiwan Government--the Ministry of Economic Affairs--in 2000, Taiwan Advance Bio-Pharmaceutical Incorporation (TABP) is the first biotechnology company in Taiwan, specializing in the food and feed diagnostic kits. Till now TABP has over 60 product lines, whose range cover most common used chemical compounds such as ractopamine and tetracycline, and a 90% domestic market share. The key features
SOFIVA GENOMICS is an assembly of authoritative physicians and expert consultants in maternal-fetal medicine, cancer medicine, medical genetics, and clinical medicine. We aspire to act as both clinical physicians and research scientists and closely join fundamental medical research and clinical diagnosis together using translational medicine so as serve our mission and value in medical genetics.Our
Microbio Co., Ltd.
MICROBIO, which was founded in 2000, has experienced over a decade of growth and remains dedicated to “novel therapeutics development and human lifestyle improvement”. MICROBIO Group's approach to innovative and responsible drug development has led to two successful drug approvals by the Taiwanese Food and Drug Administration (TFDA). In addition to drug development, we have expanded
Fountain Biopharma, Inc.
Fountain Biopharma, a subsidiary company of Microbio group, founded in December 2010 in Taiwan, focus on development of therapeutic monoclonal antibdoies for cancer and immunological conditions, aiming to meet unmet medical needs with innovation. Fountain has instituted several antibody library, high yield production cell line, upstream/downstream process development technology, analytical methods
Orient Pharma Co., Ltd.
Orient Pharma (OP) was established on Feb 1, 2008. It is focusing on the development and manufactureing of 505(b)(2) new drugs. There are more than 170 employee and 35% are dedicated to R&D. 70% of the employee own master or PhD degrees. Located in Yunlin county in the central of Taiwan, the Yunlin plant obtained the approval for PIC/S GMP from the Taiwan FDA
TAHO Pharmaceuticals Ltd.
TAHO Pharmaceuticals Ltd. (TAHO) is a specialty pharmaceutical company focused on the development of pharmaceutical products based on its drug delivery technology platforms to relieve the debilitating side effects of cancer treatment and treat central nervous (CNS) system conditions. TAHO utilizes its proprietary drug delivery technologies to create products that improve the quality of life for patients
Nang Kuang Pharmaceutical Co., Ltd.
Nang Kuang, founded in 1963, is a leading parenteral pharmaceutical company in Taiwan. The facility has passed US FDA and Japan PMDA inspections. Our major products including anticancer injections (isolator system), large volume parenterals ( LVP; PP-soft bag), aseptic parenterals (Ampoule、Vial), lyophilized injection, aseptic Pre-filled syringe、Pre-mixed IV infusion
Sinphar Pharmaceutical Co., Ltd.
Upholding its philosophy, “public's health is Sinphar's ideal” Sinphar Group has accompanied the public for almost 40 years. All these time, the company has always embraced its focus on “life, health, and technology” in developing therapeutic drugs, health care foods, and medical beauty products to provide the public with the best service for protecting their health
Vita Genomics, Inc.
The Leading Pharmacogenomics Company in Asia PacificVita Genomics, founded in March 2001, has established its headquarters and main facility in Taipei, Taiwan since January 2002. The mission of Vita Genomics is to study and understand what affects the Asian population in order to better diagnose, treat, and eventually cure diseases. Currently, in order to provide clinical and omics services to clinical
PharmaEssentia Corporation (Taipei Exchange:6446) is a fully integrated global biopharmaceutical company delivering efficacious, safe and cost-effective therapeutic products for the treatment of human diseases while aiming to bring long lasting value to stakeholders. PharmaEssentia was founded in 2003 by a group of Taiwanese-American executives and high-ranking scientists from leading U.S. biotechnology
SCI Pharmtech, Inc.
SCI Pharmtech Inc., founded by Switzerland-based Siegfried Ltd. in 1987, is now a public company listed at Taiwan Stock Exchange.Since 1989, SCI has satisfied worldwide customers with quality and cost-effective APIs, advanced intermediates, and customproducts.Our fully equipped research laboratories, pilot and production plants and experienced staff ensure timely development and cost effectiveproduction
Bora Pharmaceuticals Co., Ltd.
IntroductionBora Pharmaceutical is one of the premier pharmaceutical companies in Taiwan that covers the entire pharmaceutical supply chain from research and development all the way to sales and distribution. We provide pharmaceutical CDMO and CMO services for Taiwan domestic and global pharmaceutical companies around the world.Bora is USFDA, MHRA, and PIC/S certified, and we produce pharmaceuticals